CN101100673A - Mycobacterium tuberculosis recombination fusion protein and application thereof - Google Patents

Mycobacterium tuberculosis recombination fusion protein and application thereof Download PDF

Info

Publication number
CN101100673A
CN101100673A CNA2007101181184A CN200710118118A CN101100673A CN 101100673 A CN101100673 A CN 101100673A CN A2007101181184 A CNA2007101181184 A CN A2007101181184A CN 200710118118 A CN200710118118 A CN 200710118118A CN 101100673 A CN101100673 A CN 101100673A
Authority
CN
China
Prior art keywords
antigen
mycobacterium tuberculosis
antibody
fusion protein
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101181184A
Other languages
Chinese (zh)
Inventor
张小刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING MODERN GOLD BIOTECH Co Ltd
Original Assignee
BEIJING MODERN GOLD BIOTECH Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING MODERN GOLD BIOTECH Co Ltd filed Critical BEIJING MODERN GOLD BIOTECH Co Ltd
Priority to CNA2007101181184A priority Critical patent/CN101100673A/en
Publication of CN101100673A publication Critical patent/CN101100673A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

A mycobacterium tuberculosis recombinant fused protein, inspecting reagent kit for preparing mono-antibody and multi-body and use in protein chip are disclosed. It has better specificity and sensitivity and can be used for TB infection clinical diagnosis.

Description

A kind of mycobacterium tuberculosis recombinant fusion protein and application thereof
Technical field
The present invention relates to the genetically engineered field, relate to a kind of mycobacterium tuberculosis recombinant fusion protein and application thereof particularly.
Background technology
Tuberculosis is that (Mycobacterium tuberculosis, TB) human diseases due to the infection is the main type of mycobacterial disease, mainly passes through respiratory infectious by Mycobacterium tuberculosis.Since Germany scientist Rrobert Koch in 1882 found TB, the whole world had 200,000,000 people to die from TB approximately, and the epidemic situation development is on the rise.Estimate that according to WHO existing patient TB 2,000 ten thousand in the whole world also will have 9,000 ten thousand people morbidity as not controlling 10 years from now on.China has 3.3 hundred million tubercle bacillus affection persons now, and pulmonary tuberculosis patient more than 600 ten thousand wherein has serious communicable patient 1,500,000, dies from 250,000 people that reach lungy every year.Therefore, prevention lungy, early diagnosis and treatment in time are the problems of showing great attention to.MTB has H37Rv and two kinds of reference cultures of H37Ra, and the former is an attenuation mutant for the virulent strain latter, and they all derive from people's lung H37 strain isolated in 1934.Different with some clinical separation strains is, H37Rv to medicaments insensitive, be beneficial to genetically engineered operation and in the TB animal model, kept complete virulence, thereby this bacterial strain be widely used in the relevant biological medicine research of TB (MTb H37Rv project at Sanger Institute, NCBI).Diagnosis of tuberculosis method commonly used at present has the chest x-ray perspective and mainly relies on the microscope direct smear of patient's sputum, hydrothorax, bronchovesicular liquid to check (AFP) and culture method, and molecular biology and Serological testing, the many antigens based on high specific of these methods are set up.
The invention provides a kind of tuberculosis recombination fusion protein of producing with gene engineering method as antigen, to compare specificity stronger with antigen commonly used, with its immunodiagnosis kit as antigen prepd, that the detection that can be tuberculosis infection provides is more special, instrument accurately.
Summary of the invention
(1) technical problem that will solve
The purpose of this invention is to provide a kind of mycobacterium tuberculosis recombinant fusion protein, and the application of this mycobacterium tuberculosis recombinant fusion protein in preparation monoclonal antibody, many anti-, detection kit and protein chip is provided.
(2) technical scheme
The invention provides a kind of fusion gene of the mycobacterium tuberculosis recombinant fusion protein of encoding, its nucleotide sequence is shown in SEQ ID NO:1.
The present invention also provides a kind of mycobacterium tuberculosis recombinant fusion protein, and this recombination fusion protein is encoded by described fusion gene, and its aminoacid sequence is shown in SEQ ID NO:2.
The invention provides a kind of expression vector pET-28b-38Kd-16Kd of mycobacterium tuberculosis recombinant fusion protein, this expression vector is that described fusion gene is inserted into the recombinant plasmid that obtains on the plasmid pET-28b, and its plasmid map as shown in Figure 1.
The present invention provides a kind of engineering strain of expressing mycobacterium tuberculosis recombinant fusion protein again, and this project bacterial strain contains expression vector pET-28b-38Kd-16Kd, and its host bacterium is intestinal bacteria.
The present invention also provides a kind of mycobacterium tuberculosis antibody IgG enzyme-linked immunologic detecting kit, it comprises TB antigen and ELIAS secondary antibody, wherein TB antigen is by being to be made by aforesaid mycobacterium tuberculosis recombinant fusion protein, antigen coated amount is 1.0-8.0 μ g/ hole, and the ELIAS secondary antibody working concentration is 2.0-16.0mg/mL.Preferably, antigen coated amount is 2.0 μ g/ holes, and the ELIAS secondary antibody working concentration is 4.0mg/mL.
The invention provides a kind of mycobacterium tuberculosis antibody IgG diagnostic kit, it comprises TB antigen, colloid gold label TB antigen and nature controlling line bag by the anti-TB antibody of rabbit, and wherein said TB antigen and colloid gold label TB antigen all are to be made by aforesaid mycobacterium tuberculosis recombinant fusion protein.
Mycobacterium tuberculosis antibody IgG diagnostic kit of the present invention, antigen specking concentration is 0.25-2.0mg/mL, the working concentration of gold labelled antigen staining fluid is OD value 50.0-100.0, antigen specking amount is 0.5-1.75 μ L/cm, gold labelled antigen specking amount is 0.5-1.75 μ L/cm, the anti-TB antibody sandwich of nature controlling line concentration is 0.5-2.0mg/mL, reaction film off-period is 45-75 minute, the reaction film drying conditions is under the relative humidity 25%-30% dry 30-75 minute, gold labelled antigen pad drying conditions is under the relative humidity 25%-30% dry 3-5 hour, and the sample detection reaction time is 15 ℃~30 ℃ reactions 10-30 minute down.
Preferably, antigen specking concentration is 1.0mg/mL, the working concentration of gold labelled antigen staining fluid is an OD value 80.0, antigen specking amount is 1.0 μ L/cm, gold labelled antigen specking amount is 1.0 μ L/cm, the anti-TB antibody sandwich of nature controlling line concentration is 1.0mg/mL, reaction film off-period is 60 minutes, the reaction film drying conditions descended dry 60 minutes for relative humidity 25%-30%, gold labelled antigen pad drying conditions descended dry 4 hours for relative humidity 25%-30%, the sample detection reaction time is 15 ℃~30 ℃ reacted 25-30 minute down, and sample detection reaction time lengthening was 10 minutes when temperature was lower than 15 ℃.
The invention also discloses described mycobacterium tuberculosis recombinant fusion protein in preparation monoclonal antibody, many anti-application that reaches in the protein chip.
(3) beneficial effect
Adopt the diagnostic kit of mycobacterium tuberculosis recombinant fusion protein preparation provided by the invention, compare, have advantages such as high specificity, sensitivity height, well satisfied the needs of TB infection clinical diagnosis with the similar test kit on the market.
Description of drawings
Fig. 1 is the structure schema of expression plasmid pET-28b-38Kd-16Kd;
Fig. 2 is that expression plasmid pET-28b-38Kd-16Kd enzyme is cut the product electrophorogram, and wherein 1 represents DNAMarker, and 2,3,4 represent three positive bacterias after enzyme is cut respectively, the recombinant plasmid before 5 expression enzymes are cut;
Fig. 3 is a mycobacterium tuberculosis recombinant fusion protein purifying electrophorogram, the supernatant of 1 expression after the lysis wherein, the precipitation after the 2 expression lysises, the TB albumen of 3 expression purifying;
Fig. 4 is mycobacterium tuberculosis recombinant fusion protein Western Blot evaluation figure, and wherein preceding bacterial protein is induced in 1 expression, and the back bacterial protein is induced in 2 expressions.
Embodiment
Following examples are used to illustrate the present invention, but are not used for limiting protection scope of the present invention.
The preparation of embodiment 1 mycobacterium tuberculosis recombinant fusion protein
1.1 gene fusion
By Computer Analysis TB H37Rv genom sequence, selecting the dna sequence dna of its strong antigen epi-position 38kDa albumen (GENEBANK locus:YP_177770) and 16kDa (GENEBANK locus:NP_214765) is template, and design of amplification primers is:
The 38kD amplimer:
38-16a:atcgCATATGtgtggctcgaaaccaccgagc 61.9% Tm:72.59
38-16b:GATTGTTCATACCACCACCACCGCTGGAAATCGTCGCGATCGC 53%Tm:86
The 16kD amplimer:
38-16c:ggtggtggtggt ATGAACAATCTCGCATTG 50% Tm:76
38-16d:atcgCTC GAGCTACTTCGTGATGGCGATGC 57% Tm:74
50mL amplification system: ddH 2O 31.5mL, 10 * buffer 5.0mL, 4 * dNTP 4.0mL, the upstream and downstream primer mixes liquid 4.0mL, DNA1.5mL, Taqplus 0.2mL (1U).
Get the thalline of Mycobacterium tuberculosis H37RV, add 100mL Proteinase K (10mg/mL), put 56 ℃ of water-bath digestion 4 hours,, carry out pcr amplification with above-mentioned primer with conventional phenol/chloroform method purifying.Wherein, 38Kd upstream primer and 16Kd downstream primer have increased Nde I and Xho I restriction enzyme site respectively.
Cloned sequence is modified, product cuts behind the agarose gel electrophoresis purifying, the blob of viscose that will contain the DNA band (leads to-Beijing TAKARA company name of product: TAKARA MiniBEST Plasmid purification) illustrate and reclaim DNA by DNA fast purifying test kit available from the six directions.And then be template with being connected pcr amplification 38kDa and 16kDa fusion gene with 38kDa and 16kDa gene fragment, middlely connect with 4 Gly (ggtggtggtggt).
Plasmid DNA and 38Kd-16Kd all cut through restriction endonuclease, the 50mL system: 10 * buffer 5.0mL, and DNA 12mL, Xho I and each 15U of Nde I, ddH2O mends to 50mL; 37 ℃ of water-bath 6h.The 50mL enzyme is cut product and is separated through agarose gel electrophoresis, cutting DNA band agar block, and press the explanation of DNA fast purifying test kit and reclaim DNA.
With the fusion gene fragment cloning to pET-28b plasmid (having Xho I and Nde I restriction enzyme site), 20mL linked system: ddH available from magnificent biotech firm 2O15.0mL, 10 * buffer2.0mL, PET-28b2.0mL, Pab1.0mL, T 4Dna ligase 20U.Plasmid self connects contrast, 20mL ligation system: ddH 2O16.0mL, 10 * buffer2.0mL, PET-28b2.0mL, T4DNA ligase enzyme 20U.By behind the above-mentioned application of sample, mixing, centrifugal slightly, 14 ℃ of-16 ℃ of connections are spent the night.Transformed E .coli is coated with flat board (the LB solid medium that contains 15 mcg/ml kantlex) and chooses the order-checking of clone's upgrading grain, determines the clone that sequence is correct.The enzyme of recombinant plasmid is cut (NdeI/XhoI) electrophorogram as shown in Figure 2.
1.2 product order-checking
Sequencing primer is: the universal primer of S38-16 (GCTGGAAATCGTCGCGATCAA) and T7 promoter and T7 terminator.The mensuration synthetic and recombinant plasmid sequence pET-28b-38Kd-16Kd of all amplimers and sequencing primer all provides service by the big genome company of China.The nucleotide sequence that records the purpose fusion gene is shown in SEQ ID NO:1.
1.3 the expression of target protein, purifying
Plasmid (pET-28b-38Kd-16Kd) with the correct clone of checking, transformed into escherichia coli BL21 (DE3, available from magnificent biotech firm) the host bacterium, target protein is expressed in inclusion body: BL21 (DE3) the host bacterium that will contain the 38-16k gene is cultivated OD 0.6, with final concentration 1mM IPTG abduction delivering, collect thalline, ultrasonication, high speed centrifugation, collecting precipitation after 4 hours.The precipitation of collecting is carried out purifying with Ni post (the chelating sephrose fast flow of Pharmcia company), use following eluant solution: 300mM imidazoles, 20mM Tris, 500Mm NaCl, 8M Urea.38kDa and 16kDa fusion gene expressing protein be totally 512 amino acid, and aminoacid sequence is shown in SEQ ID NO:2.
1.4 fusion rotein calibrating
1.4.1 the mensuration of purity and molecular weight: through SDS-PAGE electrophoresis detection (albumen applied sample amount 10 μ g), be single district band, thin layer scanning identifies that purity is 95.4%.Molecular weight is about 54kD, and detected result is seen accompanying drawing 3.
1.4.2 concentration determination: measure through Folin-phenol method, as the standard reference product, antigen protein concentration is 3.5 ± 0.12mg/mL with bovine serum albumin.
1.4.3 determination of activity: measure with indirect ELISA method.Package amount 2.0 μ g/ holes use inner quality controlled serum to measure the OD value, the results are shown in Table 1.
Table 1 antigenic activity measurement result
Figure A20071011811800081
Antigen antibody reaction: adopt protein blot technology (Westem Blot), with anti-people's tuberculosis IgG antibody positive human serum test TB fused antigen, visible positive reaction, SDS-PAGE also confirms that antigenic molecular weight is 54KD.The results are shown in accompanying drawing 4.
1.4.4 fusion rotein stability is measured:
The stability of protein concn is measured, and divides the stability of measuring the protein concn of the tuberculosis antigen solution of preserving for three times, the results are shown in Table 2.
The concentration determination of table 2. tuberculoprotein
Antigen Lot number Determination of protein concentration (mg/mL)
The 1st time (3 months) The 2nd time (6 months) The 1st time (12 months)
rTBA 04-1 1.02 1.00 1.01
rTBA 04-2 1.10 1.04 1.03
rTBA 04-3 1.00 1.01 1.00
Test result shows that the protein concn of the tuberculosis antigen solution of-85 ℃ of preservations is highly stable.
The active stability of tuberculosis antigen is measured, and divides the tuberculosis antigen of three specking-85 ℃ preservations and makes colloidal gold kit, carries out measurement result with enterprise's Quality Control reference product and sees Table 3.
The result of appraisal of table 3 tuberculosis antibody enterprise Quality Control reference product
Sample For the first time For the second time For the third time
N1 - - -
N2 - - -
P1 + + +
P2 + + +
P3 + + +
P4 + + +
P5 + + +
Measurement result shows that the immunocompetence of the tuberculosis antigen of-85 ℃ of preservations is stable.
Annotate: the used sample of the present invention is provided by entire PLA tuberculosis research centre.Make by tuberculosis patient serum tuberculosis antibody IgG male the infecteds of clinical definites such as clinical bacteriology inspection and Clinical X line and negative serum, blood plasma.30 samples, the wherein negative reference material (N) of 15 anchorage people tuberculosis antibody IgG; The positive reference material (P) of 15 anchorage people tuberculosis antibody IgG.
Embodiment 2 euzymelinked immunosorbent assay (ELISA) (ELISA) detect the foundation of mycobacterium tuberculosis antibody IgG
Adopt indirect ELISA method to detect mycobacterium tuberculosis antibody IgG, can be used for the calibrating of TB antigenic activity and the auxiliary diagnosis that TB infects.For determining antigen coated amount and ELIAS secondary antibody working concentration, be specimen with positive and negative reference material, adopt the square formation volumetry to select best antigen coated amount and corresponding ELIAS secondary antibody working concentration, see the following form 4.
The selection of the sharp corresponding ELIAS secondary antibody working concentration of the best antigen coated amount of table 4
ELIAS secondary antibody IgG concentration (mg/ml) Bag is by reorganization TB antigen amount (μ g/ hole) Reference material
P1 P2 P3 N1
2.0 0.5 0.101 0.309 0.025 0.017
1.0 0.122 0.337 0.025 0.019
2.0 0.323 0.892 0.091 0.021
4.0 0.405 0.978 0.099 0.020
4.0 0.5 0.411 0.988 0.092 0.015
1.0 0.817 1.098 0.103 0.014
2.0 0.825 1.245 0.396 0.022
4.0 0.867 1.352 0.409 0.026
8.0 0.5 0.402 0.305 0.110 0.089
1.0 0.573 0.348 0.112 0.090
2.0 0.712 1.261 0.399 0.098
4.0 1.359 1.271 0.863 0.141
16.0 0.5 0.890 1.343 0.426 0.098
1.0 1.003 1.351 0.614 0.108
2.0 1.291 1.355 0.859 0.134
4.0 1.406 1.401 0.928 0.201
Annotate: with positive and negative reference material is specimen, and any a positive appears in negative reference material promptly to be judged and false positive results occurs, promptly represents with " ± " in table; Any a feminine gender appears in positive reference material promptly to be judged and false negative result occurs, promptly represents with " ± " in table.
According to test result, in antigen coated amount is 2.0 μ g/ holes, when the ELIAS secondary antibody working concentration is 4mg/ml, detected result the best, so by microwell plate and 4mg/ml ELIAS secondary antibody IgG, set up mycobacterium tuberculosis antibody IgG enzyme linked immunosorbent detection method (indirect ELISA) with TB recombinant antigen 2.0 μ g/ holes bag.
The preparation of embodiment 3 mycobacterium tuberculosis antibody IgG diagnostic kits (colloidal gold method) and performance calibrating
2.1 test kit is formed and preparation
Test kit of the present invention as antigen, adopts dual-antigen sandwich method with mycobacterium tuberculosis (TB) specific fusion protein of purifying.Add serum to be checked during use, as containing anti-TB specific antibody in the sample, then combine with golden mark TB antigen earlier, moving ahead combines the formation mixture again and presents purple-red colour with the corresponding TB antigen on film surface.As nonreactive TB specific antibody in the sample, then have only the nature controlling line color, its colour intensity directly and the amount of the anti-TB specific antibody IgG that exists in the sample proportional.
The main moiety of test kit is a test panel, comprises sample application zone, the antigen coated film of gold mark district, antigen coated detection zone, Quality Control district and absorbent pad district.
2.1.1 the nature controlling line bag is by the anti-TB antibody of rabbit: (available from Beijing Sai Dike biotech company, protein concentration is 4.0 ± 0.15mg/mL, immune agar double diffusion tires 〉=and 1: 16).
2.1.2 colloid gold label TB antigen: Radioactive colloidal gold diameter 30nm colloid gold particle, stoste optical density(OD) OD is not less than 10.0.
2.1.3 condition optimizing
2.1.3.1 determining of antigen and the antigen coated concentration of gold mark: adopt the square formation titration to select best antigen coated concentration and corresponding golden labelled antigen working concentration, see the following form 5.
The selection of best antigen of table 5 and corresponding golden labelled antigen working concentration
Labelled antigen concentration (OD value) Antigen concentration (mg/mL)
2.00 1.5 1.25 1.00 0.75 0.50 0.25
50.0 60.0 70.0 80.0 90.0 100.0 -/+ -/+ -/+ +/+ +/+ +/+ -/+ -/+ -/+ -/+ -/+ +/+ -/+ -/+ -/+ -/+ -/+ -/+ -/- -/+ -/+ -/+ -/+ -/+ -/- -/- -/+ -/+ -/+ -/+ -/- -/- -/- -/- -/- -/+ -/- -/- -/- -/- -/- -/-
Annotate: with positive and negative serum Quality Control reference product is specimen, and any a positive appears in negative reference material promptly to be judged and false positive results occurs, promptly represents with "+/ " in table; Any a feminine gender appears in positive reference material promptly to be judged and false negative result occurs, promptly represents with "/" in table.
According to test result, be that 1.0 μ L/cm and golden labelled antigen specking amount are under the condition of 1.0 μ L/cm in antigen specking amount, selected best antigen specking concentration is 1.0mg/mL, the working concentration of golden labelled antigen staining fluid is an OD value 80.0.
2.1.3.2 determining of best antigen specking amount: determining that best antigen specking concentration is that 1.0mg/mL and best golden labelled antigen specking concentration are on the basis of OD value 80.0, adopting the square formation titration to select best antigen specking amount (seeing Table 6)
Determining of the best antigen specking of table 6 amount
Sample NO Antigen specking amount (μ L/cm)
1.75 1.5 1.25 1.00 0.75 0.50
N1 N2 N3 P1 P2 P4 P5 - - ± + + + + - - - + + + + - - - + + + + - + + + + -- -- - + + + + - - - + - - +
According to test result, selected best antigen specking amount is 1.0 μ L/cm.
2.1.3.3 determining of best golden labelled antigen specking amount; Determining that best antigen specking concentration is 1.0mg/mL, the specking amount is that 1.0 μ L/cm and best golden labelled antigen specking concentration are on the basis of OD value 80.0, adopts the square formation titration to select best golden labelled antigen specking amount (seeing Table 7).
Determining of the best golden labelled antigen specking amount of table 7
Sample NO Gold labelled antigen specking amount (μ L/cm)
1.75 1.5 1.25 1.00 0.75 0.50
N1 N2 N3 P1 P2 P4 - - - + + + - - - + + + - - -- + + + - - - + + + - - - + + + - - + + -
According to test result, selected best golden labelled antigen specking amount is 1.0 μ L/cm.
2.1.3.4 the selection of the anti-TB antibody sandwich of nature controlling line concentration
Anti-TB antibody sandwich amount is 1 μ L/cm.The experimental result that the anti-TB bag of nature controlling line is selected by concentration sees Table 8.
The anti-TB bag of table 8 nature controlling line is by the selection of concentration
Bag is by anti-TB antibody concentration (mg/mL) Anti-TB negative reaction serum
The test result test result Reacted 5 minutes 0.5 -
1.0 +
1.5 +
2.0 ++
Reacted 10 minutes 0.5 +
1.0 ++
1.5 +++
2.0 +++
Reacted 15 minutes 0.5 +
1.0 +++
1.5 +++
2.0 +++
Reacted 20 minutes 0.5 ++
1.0 +++
1.5 +++
2.0 +++
Reacted 25 minutes 0.5 ++
1.0 +++
1.5 +++
2.0 +++
Reacted 30 minutes 0.5 ++
1.0 +++
1.5 +++
2.0 +++
-: control line does not appear; +: control line is clear; +++: control line line is clear thick.
Table 8 shows that used gold mark antigen has reactive preferably in the anti-TB antibody of rabbit and this test.1.0mg/mL the anti-TB of concentration bag can be shown the contrast effect basically preferably, continues to improve antibody concentration and fails obviously to improve response intensity.Thereby the concentration of selecting the anti-TB of 1.0mg/mL as the nature controlling line bag by concentration.
2.1.3.5 the selection of reaction film off-period
The nitrocellulose filter bag by TB antigen and anti-TB antibody after, can reduce nonspecific reaction effectively through confining liquid sealing.Selection experimental result to reaction film off-period sees Table 9.
The selection experimental result of table 9 reaction film off-period (37 ℃)
Reaction times 15 minutes 30 minutes 45 minutes 60 minutes 75 minutes
Negative serum × × - - -
Positive serum × × ++ ++ ++
-: negative reaction; ±: probable positive; ++ positive reaction; *: the reaction film blurred background
Table 9 shows that off-period, difference had certain influence to correct reflection experimental result.Off-period, too short meeting caused the reaction film blurred background, influenced interpretation as a result.This result of experiment shows sealing 45 minutes-75 minutes, and sealing effect is better, helps to improve the accuracy of experimental result.Selecting sealing was production control condition in 60 minutes.
2.1.3.6 the selection of reaction film drying conditions
The experimental result that table 10 reaction film drying conditions is selected
Figure A20071011811800141
The drying conditions that reaction film suits is not only relevant with the sensitivity of reagent, and more close with the stability relation of reagent.The result of table 10 shows, is under 20% environment in relative humidity, lacks the then poor stability of reagent time of drying, and time of drying, length then influenced the accuracy of reaction result.In relative humidity is 25%, 30% environment when being 45 minutes, 60 minutes, 75 minutes following time of drying, and reaction result is more approaching, and susceptibility and stability are preferably all arranged.Consider controllability in process of production, adopt relative humidity 25%-30%, 60 minutes condition of drying to be the drying conditions in producing.
2.1.3.7 the selection of golden labelled antigen pad time of drying
The experimental result of table 11 gold labelled antigen pad selection time of drying
Figure A20071011811800151
Gold labelled antigen pad drying is under 37 ℃ of conditions.Table 11 shows that dry environment relative humidity is crossed to hang down may influence response intensity.Under relatively more suitable dry environment, 3 hours time of drying, 4 hours, 5 hours, drying effect was more approaching, and the reaction sensibility of reagent and stability are all better.So select relative humidity 25%-30% for use, be production control condition in dry 4 hours.
2.1.3.8 the selection of sample detection reaction time
The table 12 sample detection reaction time advance to select experimental result (A)
The selection experimental result (B) of table 13 sample detection reaction time
Figure A20071011811800161
Table 12 and table 13 show, under room temperature condition usually (15 ℃~30 ℃), the anti-TB positive or strong positive reaction serum clear and definite positive reaction result can occur in 5-10 minute after reaction.When the weak positive reaction serum of anti-TB reacts at normal temperatures, need the long reaction times, can obtain clear and definite positive reaction result in the time of 25-30 minute in reaction.Anti-TB negative serum is reflected in 30 minutes under common room temperature condition (15 ℃~30 ℃), can correctly reflect substantially to measure serum character.Reaction times is long might cause false positive.Therefore, the time of judgement is as a result determined judge reaction result in the time of 25-30 minute in reaction.Consider that in particular cases the room temperature of possible real work is lower than 15 ℃, influences reaction result, take to prolong the measure in 10 minute reaction times, also can obtain satisfied result.
2.1.4 the manufacturing of test kit
1) the bag quilt of check-out console: the precut of NC film, stickup, antigen is diluted to optimum concn with pH7.2,0.02mol/L PBS damping fluid, the anti-TB antibody of Quality Control is diluted to optimum concn with pH7.2,0.02mol/L PBS damping fluid, respectively with the optimal conditions specking on the NC film, drying, sealing, drying;
Confining liquid prescription: 0.02mol/L PBS damping fluid (pH7.2 contains 0.25% skim-milk).
2) stickup of golden labelled antigen: with the golden labelled antigen solution of 0.05mol/LTris-HCl damping fluid (pH8.0) preparation, bag is pasted on bag by good check-out console by on the glass fibre mould after the drying;
3) assembling: check-out console cuts into test strip, assembles, packs.
2.1.5 detection method and interpretation of result
1) take out test panel, place on the plane operations platform, balance is to room temperature.
2) application of sample: micro sample adding appliance adds undiluted test serum 100 μ l in well.
3) observe and write down the result in 15-20 minute.The strong positive result can occur at 5 minutes, and the weak positive and negative findings need be waited for observation in 20 minutes.Positive: two red-purple lines appear in interpretation window (C and T position); Negative: red-purple lines (C position) only appear in the interpretation window; Invalid: the interpretation window does not have the red-purple lines.
2.2 test kit performance evaluation
2.2.1 detected result to 30 parts of TB reference materials
Use the test kit of the present invention's preparation, TB antibody reference material is detected, detected result sees Table 14.
Table 14 pair 30 parts of TB antibody reference material detected results
Anti-TB antibody positive reaction serum Anti-TB negative antibody reaction serum
Sample The result Sample The result
P1 ++ N1 -
P2 ++ N2 -
P3 ++ N3 -
P4 +++ N4 -
P5 ++ N5 -
P6 ++ N6 -
P7 ++ N7 -
P8 ++ N8 -
P9 +++ N9 -
P10 ++ N10 -
P11 +++ N11 -
P12 ++ N12 -
P13 + N13 -
P14 ++ N14 -
P15 +++ N15 -
Accuracy serum
C1 + C1 +
C1 + C1 +
C1 + C1 +
C1 + C1 +
C1 + C1 +
-: negative reaction; +: positive reaction; ++: than strong positive reaction; +++: strong positive reaction.
From the test the result as can be seen, negative, positive coincidence rate all reaches 100%.Therefore we think that it is feasible adopting this detection system.
2.2.2 cross reaction test to antibody positive serum such as HBV, HCV, HAV and syphilis
Adopt the cross reaction of test kit of the present invention to HBV (hepatitis B), HCV (hepatitis C), HAV (hepatitis A), cancer and non-tuberculosis respiratory system patients serum, with its specificity of further evaluation, above-mentioned affirmation patient blood sample is tested, be the results are shown in following table.
The cross reaction test result of antibody positive serum such as table 15HBV, HCV, HAV and syphilis
Be subjected to the grouping of sample product Examination test kit (golden mark method) Be subjected to sample product source
Number positive Negative number Add up to Positive rate (%)
HBV antibody positive serum 0 50 50 0.00 Entire PLA tuberculosis center
HCV antibody positive serum 0 50 50 0.00 The same
HAV antibody positive serum 0 40 40 0.00 The same
Cancer patients's serum 0 40 40 0.00 The same
Non-tuberculosis respiratory system patients serum 0 100 100 0.00 The same
Add up to 0 280 28 0.00
The result shows that this test kit and above-mentioned patient's blood sample no cross reaction take place.
2.2.3 the cross reaction to chaff interferences such as syphilis (RF) positive serum, blood fat, bilirubin and oxyphorases detects
The test result of chaff interferences such as table 16 pair syphilis (RF) positive serum, blood fat, bilirubin and oxyphorase
Be subjected to the grouping of sample product Examination test kit (golden mark method) Be subjected to sample product source
Number positive Negative number Add up to Positive rate (%)
The RF positive serum 0 30 30 0.00 Entire PLA tuberculosis center
Hyperlipidemia serum
0 60 60 0.00 The same
The jaundice human serum 1 59 60 1.67 The same
Blood plasma behind the haemolysis 0 60 60 0.00 The same
Add up to 1 209 210 0.48
The result shows that the cross reaction of this test kit and chaff interferences such as RF positive serum, blood fat, bilirubin and oxyphorase does not surpass the false positive rate of normal human serum sample.
2.2.4 relatively wait testing data with external like product
Make comparisons with the tuberculosis antibody quick diagnosis reagent kit of new generation that the general biological medicine of test kit of the present invention and Shanghai Australia company limited produces.215 parts of positive serums and XX negative serum are compared detection, the results are shown in following table
The compare test result of table 17 and the general tuberculosis antibody test kit of Shanghai Australia
Beijing modern times are up to gold mark detection kit result Shanghai Australia general tuberculosis antibody test kit detected result Add up to
Positive Negative
Positive negative the total 174(A) 26(C) 200(A+C) 2(B) 228(D) 230(B+D) 176(A+B) 254(C+D) 430(A+B+C+D)
Verity and predictive value's computational analysis:
Table 18 verity and predictive value's computational analysis
Method of calculation Calculation result
Sensitivity=A/ (A+C) * 100% 174/(174+26)=87.0%
Specific degree=D/ (B+D) * 100% 228/(2+228)=99.1%
The * 100% of false positive rate=B/B+D) 2/(2+228)=0.8%
The * 100% of false negative rate=C/B+D) 26/(2+228)=11.3%
Thick consistent=(A+D)/(A+B+C+D) * 100% (174+228)/(174+2+26+228)=93.4%
Adjust consistence=1/4 (A/ (A+B)+A/ (A+C)+D/ (C+D)+D/ (B+D)) * 100% 1/4(174/(174+2)+174/(174+26)+228/(26+228) +228/(2+228))=93.6%
Youden index=(A/ (A+C)+D/ (B+D))-1 (174/(174+26)+228/(2+228))=0.861
Predictive value=the A/ of positive test (A+B) * 100% 174/(174+2)=98.8
Predictive value=the D/ of negative test (C+D) * 100% 228/(26+228)=89.7%
The detection coincidence rate of the general tuberculosis antibody test kit of test kit of the present invention and reference product Shanghai Australia is 93.49%.
2.2.5 clinical examination
Shenyang Hospital for Thoracics, the clinical examination result of Anhui Province's lung hospital of section and three families of Taiyuan City tuberculosis hospital is as follows:
Table 19 tuberculosis antibody IgG detected result
Unit Be subjected to the inspection number Phlegm bacterium (+) Phlegm bacterium (-) Non-tuberculosis disease The blood donor
Taiyuan City tuberculosis hospital of Shenyang Hospital for Thoracics of Anhui Province hospital of lung section 350 350 350 100(92)* 100(83) 100(82) 100(63) 100(63) 100(51) 100(8) 100(10) 100(11) 50(2) 50(2) 50(3)
* detect positive routine number for test kit in ()
Table 20 tuberculosis antibody IgG detected result
Grouping Anhui Province hospital of lung section (%) Shenyang Hospital for Thoracics (%) Taiyuan City tuberculosis hospital (%)
The non-tuberculosis respiratory disease of tuberculosis patient group blood donor group 77.5(155/200) 11.0(11/100) 4.0(2/50) 73.0(146/200) 10.0(10/100) 4.0(2/50) 66.5(133/200) 11.0(11/100) 6.0(3/50)
Through Shenyang Hospital for Thoracics, the clinical examination result of Anhui Province hospital of lung section and three families of Taiyuan City tuberculosis hospital, test kit of the present invention (colloidal gold method) has reached the specification of quality of national regulation, and with the similar products at home and abroad not statistically significant on mass discrepancy.
Sequence table
<110〉Beijing modern times are up to Bioisystech Co., Ltd
<120〉a kind of mycobacterium tuberculosis recombinant fusion protein and application thereof
<130>GD0702
<160>2
<170>PatentIn version 3.3
<210>1
<211>1530
<212>DNA
<213〉Mycobacterium tuberculosis (Mycobacterium tuberculosis)
<400>1
tgtggctcga aaccaccgag cggttcgcct gaaacgggcg ccggcgccgg tactgtcgcg 60
actacccccg cgtcgtcgcc ggtgacgttg gcggagaccg gtagcacgct gctctacccg 120
ctgttcacct gtggggtccg gcctttcacg agaggtatcc gaacgtcacg atcaccgctc 180
agggcaccgg ttctggtgcc gggatcgcgc aggccgccgc cgggacggtc aacattgggg 240
cctccgacgc ctattgtcgg aaggtgatat ggccgcgcac aaggggctga tgaacatcgc 300
gctagccatc tccgctcagc aggtcaacta caacctgccc ggagtgagcg agcacctcaa 360
gctgaacgga aaagtcctgg cgccatgtac cagggcacca tcaaaacctg ggacgacccg 420
cagatcgctg cgctcaaccc cggcgtgaac ctgcccggca ccgcggtagt tccgctgcac 480
cgctccgacg ggtccggtga caccttctgt tcacccagta cctgtccaag caagatcccg 540
agggctgggg caagtcgccc ggcttcggca ccaccgtcga cttcccggcg gtgccgggtg 600
cgctgggtga gaacggcaac ggcggcatgg tgaccgttgc gccgagacac cgggctgcgt 660
ggcctatatc ggcatcagct tcctcgacca ggccagtcaa cggggactcg gcgaggccca 720
actaggcaat agctctggca atttcttgtt gcccgacgcg caagcattca ggccgcggcg 780
gctggcttcg catcgaaaac cccggcgaac caggcgattt cgatgatcga cgggcccgcc 840
ccggacggct acccgatcat caactacgag tacgccatcg tcaacaaccg caaaaggacg 900
ccgccaccgc gcagaccttg caggcatttc tgcactgggc gatcaccgac ggcaacaagg 960
cctcgttcct cgaccaggtt catttccagc cgctgccgcc cgcggtggtg aagttgctga 1020
cgcgttgatc gcgacgattt ccagcggtgg tggtggtatg aacaatctcg cattgtggtc 1080
gcgtccggtg tgggacgttg agccctggga ccgctggcta cgtgacttct tcggccctgc 1140
cgcacgacgg actggtaccg cccggtcgcc ggagacttca cgccggccgc cgagatcgtc 1200
aaggatggcg cgacgcggtg gtccgtttgg aactgcccgg cattgacgtc gacaaggacg 1260
tcaacgtcgg cttgaccctg gccagccggt gagccgcctg gtgatccgcg gcgaacaccg 1320
cgacgagcac acgcaagcgc cggagacaaa gacggccgca ccctgcgtga gatccgctac 1380
ggatcattcc gccgccgttc cggctgcccg cgcacgtcac cagcgaggcc atcgcggctt 1440
cctatgacgc cggtgtgctg accgccgggt tgccggcgcc tacaaggccc cagccgaaac 1500
tcaggcgcag cgcatcgcca tacgaagtag 1530
<210>2
<211>512
<212>PRT
<213〉Mycobacterium tuberculosis (Mycobacterium tube rculosis)
<220>
<221>misc_feature
<222>(349)..(349)
<223>Xaa can be any naturally occurring amino acid
<400>2
Cys Gly Ser Lys Pro Pro Ser Gly Ser Pro Glu Thr Gly Ala Gly Ala
1 5 10 15
Gly Thr Val Ala Thr Thr Pro Ala Ser Ser Pro Val Thr Leu Ala Glu
20 25 30
Thr Gly Ser Thr Leu Leu Tyr Pro Leu Phe Asn Leu Trp Gly Pro Ala
35 40 45
Phe His Glu Arg Tyr Pro Asn Val Thr Ile Thr Ala Gln Gly Thr Gly
50 55 60
Ser Gly Ala Gly Ile Ala Gln Ala Ala Ala Gly Thr Val Asn Ile Gly
65 70 75 80
Ala Ser Asp Ala Tyr Leu Ser Glu Gly Asp Met Ala Ala His Lys Gly
85 90 95
Leu Met Asn Ile Ala Leu Ala Ile Ser Ala Gln Gln Val Asn Tyr Asn
100 105 110
Leu Pro Gly Val Ser Glu His Leu Lys Leu Asn Gly Lys Val Leu Ala
115 120 125
Ala Met Tyr Gln Gly Thr Ile Lys Thr Trp Asp Asp Pro Gln Ile Ala
130 135 140
Ala Leu Asn Pro Gly Val Asn Leu Pro Gly Thr Ala Val Val Pro Leu
145 150 155 160
His Arg Ser Asp Gly Ser Gly Asp Thr Phe Leu Phe Thr Gln Tyr Leu
165 170 175
Ser Lys Gln Asp Pro Glu Gly Trp Gly Lys Ser Pro Gly Phe Gly Thr
180 185 190
Thr Val Asp Phe Pro Ala Val Pro Gly Ala Leu Gly Glu Asn Gly Asn
195 200 205
Gly Gly Met Val Thr Gly Cys Ala Glu Thr Pro Gly Cys Val Ala Tyr
210 215 220
Ile Gly Ile Ser Phe Leu Asp Gln Ala Ser Gln Arg Gly Leu Gly Glu
225 230 235 240
Ala Gln Leu Gly Asn Ser Ser Gly Asn Phe Leu Leu Pro Asp Ala Gln
245 250 255
Ser Ile Gln Ala Ala Ala Ala Gly Phe Ala Ser Lys Thr Pro Ala Asn
260 265 270
Gln Ala Ile Ser Met Ile Asp Gly Pro Ala Pro Asp Gly Tyr Pro Ile
275 280 285
Ile Asn Tyr Glu Tyr Ala Ile Val Asn Asn Arg Gln Lys Asp Ala Ala
290 295 300
Thr Ala Gln Thr Leu Gln Ala Phe Leu His Trp Ala Ile Thr Asp Gly
305 310 315 320
Asn Lys Ala Ser Phe Leu Asp Gln Val His Phe Gln Pro Leu Pro Pro
325 330 335
Ala Val Val Lys Leu Ser Asp Ala Leu Ile Ala Thr Xaa Gly Gly Gly
340 345 350
Gly Met Asn Asn Leu Ala Leu Trp Ser Arg Pro Val Trp Asp Val Glu
355 360 365
Pro Trp Asp Arg Trp Leu Arg Asp Phe Phe Gly Pro Ala Ala Thr Thr
370 375 380
Asp Trp Tyr Arg Pro Val Ala Gly Asp Phe Thr Pro Ala Ala Glu Ile
385 390 395 400
Val Lys Asp Gly Asp Asp Ala Val Val Arg Leu Glu Leu Pro Gly Ile
405 410 415
Asp Val Asp Lys Asp Val Asn Val Glu Leu Asp Pro Gly Gln Pro Val
420 425 430
Ser Arg Leu Val Ile Arg Gly Glu His Arg Asp Glu His Thr Gln Asp
435 440 445
Ala Gly Asp Lys Asp Gly Arg Thr Leu Arg Glu Ile Arg Tyr Gly Ser
450 455 460
Phe Arg Arg Ser Phe Arg Leu Pro Ala His Val Thr Ser Glu Ala ILe
465 470 475 480
Ala Ala Ser Tyr Asp Ala Gly Val Leu Thr Val Arg Val Ala Gly Ala
485 490 495
Tyr Lys Ala Pro Ala Glu Thr Gln Ala Gln Arg Ile Ala Ile Thr Lys
500 505 510

Claims (10)

1, a kind of fusion gene of the mycobacterium tuberculosis recombinant fusion protein of encoding, its nucleotide sequence is shown in SEQ ID NO:1.
2, a kind of mycobacterium tuberculosis recombinant fusion protein is characterized in that it by the described fusion gene coding of claim 1, and its aminoacid sequence is shown in SEQ ID NO:2.
3, a kind of expression vector pET-28b-38Kd-16 Kd of mycobacterium tuberculosis recombinant fusion protein is characterized in that it is that the described gene of claim 1 is inserted into the recombinant plasmid that obtains on the plasmid pET-28b, and its plasmid map as shown in Figure 1.
4, a kind of engineering strain of expressing mycobacterium tuberculosis recombinant fusion protein is characterized in that it contains the described expression vector pET-28b-38Kd-16 of claim 3 Kd, and its host bacterium is intestinal bacteria.
5, a kind of mycobacterium tuberculosis antibody IgG enzyme-linked immunologic detecting kit, it comprises TB antigen and ELIAS secondary antibody, it is characterized in that described TB antigen is to be made by recombination fusion protein according to claim 2, wherein antigen coated amount is 1.0-8.0 μ g/ hole, and the ELIAS secondary antibody working concentration is 2.0-16.0mg/mL.
6, detection kit according to claim 5 is characterized in that antigen coated amount is 2.0 μ g/ holes, and the ELIAS secondary antibody working concentration is 4.0mg/mL.
7, a kind of mycobacterium tuberculosis antibody IgG diagnostic kit, it comprises TB antigen, colloid gold label TB antigen and nature controlling line bag by the anti-TB antibody of rabbit, it is characterized in that described TB antigen and colloid gold label TB antigen all are to be made by recombination fusion protein according to claim 2.
8, test kit according to claim 7, it is characterized in that antigen specking concentration is 0.25-2.0mg/mL, the working concentration of gold labelled antigen staining fluid is OD value 50.0-100.0, antigen specking amount is 0.5-1.75 μ L/cm, gold labelled antigen specking amount is 0.5-1.75 μ L/cm, the anti-TB antibody sandwich of nature controlling line concentration is 0.5-2.0mg/mL, reaction film off-period is 45-75 minute, the reaction film drying conditions is under the relative humidity 25%-30% dry 30-75 minute, gold labelled antigen pad drying conditions is under the relative humidity 25%-30% dry 3-5 hour, and the sample detection reaction time is 15 ℃~30 ℃ reactions 10-30 minute down.
9, test kit according to claim 8, it is characterized in that antigen specking concentration is 1.0mg/mL, the working concentration of gold labelled antigen staining fluid is an OD value 80.0, antigen specking amount is 1.0 μ L/cm, gold labelled antigen specking amount is 1.0 μ L/cm, the anti-TB antibody sandwich of nature controlling line concentration is 1.0mg/mL, reaction film off-period is 60 minutes, the reaction film drying conditions descended dry 60 minutes for relative humidity 25%-30%, gold labelled antigen pad drying conditions descended dry 4 hours for relative humidity 25%-30%, the sample detection reaction time is 15 ℃~30 ℃ reacted 25-30 minute down, and sample detection reaction time lengthening was 10 minutes when temperature was lower than 15 ℃.
10, the application of mycobacterium tuberculosis recombinant fusion protein according to claim 2 in preparation monoclonal antibody, many anti-, detection kit and protein chip.
CNA2007101181184A 2007-06-29 2007-06-29 Mycobacterium tuberculosis recombination fusion protein and application thereof Pending CN101100673A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007101181184A CN101100673A (en) 2007-06-29 2007-06-29 Mycobacterium tuberculosis recombination fusion protein and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007101181184A CN101100673A (en) 2007-06-29 2007-06-29 Mycobacterium tuberculosis recombination fusion protein and application thereof

Publications (1)

Publication Number Publication Date
CN101100673A true CN101100673A (en) 2008-01-09

Family

ID=39035121

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101181184A Pending CN101100673A (en) 2007-06-29 2007-06-29 Mycobacterium tuberculosis recombination fusion protein and application thereof

Country Status (1)

Country Link
CN (1) CN101100673A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101914563A (en) * 2010-07-20 2010-12-15 沈阳市胸科医院 Mycobacterium tuberculosis 38Kd-16Kd-CFP10 recombinant fusion protein and application thereof
CN101235090B (en) * 2008-01-31 2012-02-22 复旦大学 Specificity fusion protein applied to tuberculosis rapid diagnosis and its construction method
CN102660559A (en) * 2012-04-28 2012-09-12 吉林大学 Mycobacterium tuberculosis (TB) recombinant protein and preparation method thereof
CN101403746B (en) * 2008-07-18 2013-04-10 深圳市菲鹏生物股份有限公司 Conjugate used for immunity detection
CN111443198A (en) * 2020-03-19 2020-07-24 济南杏恩生物科技有限公司 Method for rapidly detecting tubercle bacillus secretory protein based on colloidal gold method
NL2027721B1 (en) * 2021-03-08 2022-09-26 Tomorrows Ip Ltd Method of preparing a detection substrate, detection substrate, and uses thereof
CN116041454A (en) * 2022-12-07 2023-05-02 中国疾病预防控制中心传染病预防控制所 Mycobacterium tuberculosis protein antigen mixture, multi-antigen fusion protein, encoding gene and application

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101235090B (en) * 2008-01-31 2012-02-22 复旦大学 Specificity fusion protein applied to tuberculosis rapid diagnosis and its construction method
CN101403746B (en) * 2008-07-18 2013-04-10 深圳市菲鹏生物股份有限公司 Conjugate used for immunity detection
CN101914563A (en) * 2010-07-20 2010-12-15 沈阳市胸科医院 Mycobacterium tuberculosis 38Kd-16Kd-CFP10 recombinant fusion protein and application thereof
CN102660559A (en) * 2012-04-28 2012-09-12 吉林大学 Mycobacterium tuberculosis (TB) recombinant protein and preparation method thereof
CN111443198A (en) * 2020-03-19 2020-07-24 济南杏恩生物科技有限公司 Method for rapidly detecting tubercle bacillus secretory protein based on colloidal gold method
NL2027721B1 (en) * 2021-03-08 2022-09-26 Tomorrows Ip Ltd Method of preparing a detection substrate, detection substrate, and uses thereof
CN116041454A (en) * 2022-12-07 2023-05-02 中国疾病预防控制中心传染病预防控制所 Mycobacterium tuberculosis protein antigen mixture, multi-antigen fusion protein, encoding gene and application
CN116041454B (en) * 2022-12-07 2023-12-26 中国疾病预防控制中心传染病预防控制所 Mycobacterium tuberculosis protein antigen mixture, multi-antigen fusion protein, encoding gene and application

Similar Documents

Publication Publication Date Title
CN101100673A (en) Mycobacterium tuberculosis recombination fusion protein and application thereof
JP5033127B2 (en) Methods and compositions for detecting herpes simplex virus type 2
CN101968490A (en) Indirect ELISA (Enzyme-Linked Immunosorbent Assay) method and kit for detecting haemophilus parasuis antibodies
CN101294964A (en) Reagent and method for detecting active tuberculosis and tuberculosis dormant infection
CN103059109B (en) Mycoplasma pneumonia antigen, preparation method and immunodetection kit
CN101914563A (en) Mycobacterium tuberculosis 38Kd-16Kd-CFP10 recombinant fusion protein and application thereof
CN114736290B (en) Nanometer antibody capable of recognizing porcine pseudorabies virus with high accuracy and sensitivity, preparation method and application
KR20170106407A (en) Immunological detection and kit of mycoplasma pneumoniae
CN101363858B (en) Test paper strip for detecting PRRSV antibody colloidal gold, method for making same and applications
KR101814757B1 (en) Diagnosis Method for Foot-Mouse Disease Virus(FMDV) using Non Structural Proteins 3AB of FMD-Virus and its Specific Monoclonal Antibodies, and Diagnostic Kit using the method
CN101838660A (en) Mycobacterium tuberculosis recombinant fusion protein and application thereof
CN110964089B (en) Mycoplasma pneumoniae antigen
KR20160075964A (en) Diagnosis Method for Classical Swine Fever(CSF) using E2 proteins of CSF-Virus and its Specific Monoclonal Antibodies, and Diagnostic Kit using the method
CN103834668A (en) Recombination mycoplasma pneumoniae protein and application thereof
CN101914562A (en) Mycobacterium tuberculosis 38Kd-11Kd-CFP10 recombinant fusion protein and application thereof
CN101509002B (en) Recombinant rubella virus protein and uses thereof
CN101508999B (en) Recombinant toxoplasma protein and uses thereof
CN102660559B (en) Mycobacterium tuberculosis (TB) recombinant protein and preparation method thereof
CN110794135A (en) GPBB latex enhanced turbidimetry detection kit and preparation and use methods thereof
CN102925462A (en) Chlamydia trachomatis recombinant protein and preparation method thereof
CN102899334B (en) Mycobacterium tuberculosis recombinant protein and preparation method thereof
EP3792630A1 (en) Lateral flow immunoassay device for detection of candida infection
Khan et al. Molecular characterization of pneumococcal surface protein A (PspA), serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae strains isolated from Pakistan
CN112646007B (en) Combined protein for detecting mycobacterium tuberculosis and detection reagent
CN101705233B (en) Recombinant human herpes simplex virus I protein HSV I gG and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20080109